Results for tag: "Angiopoietin Inhibitor"

The Angiopoietin Inhibitor market is a subset of the Cardiovascular Drugs market, which focuses on treatments for diseases of the heart and circulatory system. Angiopoietin Inhibitors are a type of drug that works by blocking the action of angiopoietin proteins, which are involved in the formation of new blood vessels. This type of drug is used to treat a variety of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and stroke. Angiopoietin Inhibitors are typically administered intravenously, and are often used in combination with other drugs to maximize their effectiveness. They are also used to reduce the risk of complications from cardiovascular diseases, such as heart attack and stroke. Some companies in the Angiopoietin Inhibitor market include Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more